About
Develops Tripair™, a minimally invasive transcatheter valve repair system to treat tricuspid regurgitation; the company aims to simplify the procedure to expand access to patients who are currently untreated. Tripair is an investigational medical device intended to enable safer, more accessible tricuspid valve repair.
Explore Coramaze Technologies (Tripair)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.